NOT FOR DISTRIBUTION
Header cover image

Market Cap

€28.5m

Last Updated

2021/05/10 16:23 UTC

Data Sources

Company Financials

Executive Summary

Biokarpet S.A. engages in the metallurgy, textile, and information technology sectors in Greece, rest of European union, and internationally. More Details


Snowflake Analysis

Poor track record with worrying balance sheet.

Share Price & News

How has Biokarpet's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: BIOKA is more volatile than 90% of Greek stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: BIOKA's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Greek stocks.


Market Performance


7 Day Return

-1.6%

BIOKA

-1.7%

GR Metals and Mining

-0.2%

GR Market


1 Year Return

70.2%

BIOKA

74.3%

GR Metals and Mining

-11.7%

GR Market

Return vs Industry: BIOKA underperformed the Greek Metals and Mining industry which returned 74.7% over the past year.

Return vs Market: BIOKA exceeded the Greek Market which returned -12.2% over the past year.


Shareholder returns

BIOKAIndustryMarket
7 Day-1.6%-1.7%-0.2%
30 Day9.1%-8.3%-5.5%
90 Day53.8%27.4%-13.1%
1 Year70.2%70.2%77.4%74.3%-10.1%-11.7%
3 Year75.2%75.2%36.0%30.2%-53.2%-54.7%
5 Year233.3%233.3%295.2%260.6%58.8%38.2%

Long-Term Price Volatility Vs. Market

How volatile is Biokarpet's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Biokarpet undervalued compared to its fair value and its price relative to the market?

131.56x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate BIOKA's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate BIOKA's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: BIOKA is poor value based on its PE Ratio (131.6x) compared to the GR Metals and Mining industry average (18.3x).

PE vs Market: BIOKA is poor value based on its PE Ratio (131.6x) compared to the Greek market (20.1x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate BIOKA's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: BIOKA's PB Ratio (1x) is in line with the GR Metals and Mining industry average.


Future Growth

How is Biokarpet forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

4.7%

Forecasted Materials industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Biokarpet has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Biokarpet performed over the past 5 years?

55.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: BIOKA has a large one-off gain of €352.3K impacting its December 31 2020 financial results.

Growing Profit Margin: BIOKA's current net profit margins (0.2%) are lower than last year (1%).


Past Earnings Growth Analysis

Earnings Trend: BIOKA has become profitable over the past 5 years, growing earnings by 55.9% per year.

Accelerating Growth: BIOKA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: BIOKA had negative earnings growth (-82.1%) over the past year, making it difficult to compare to the Metals and Mining industry average (10.6%).


Return on Equity

High ROE: BIOKA's Return on Equity (0.8%) is considered low.


Financial Health

How is Biokarpet's financial position?


Financial Position Analysis

Short Term Liabilities: BIOKA's short term assets (€73.2M) exceed its short term liabilities (€40.3M).

Long Term Liabilities: BIOKA's short term assets (€73.2M) do not cover its long term liabilities (€74.1M).


Debt to Equity History and Analysis

Debt Level: BIOKA's debt to equity ratio (290.4%) is considered high.

Reducing Debt: BIOKA's debt to equity ratio has increased from 229.5% to 290.4% over the past 5 years.

Debt Coverage: BIOKA's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: BIOKA's interest payments on its debt are not well covered by EBIT (1.2x coverage).


Balance Sheet


Dividend

What is Biokarpet current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate BIOKA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate BIOKA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if BIOKA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if BIOKA's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: BIOKA is not paying a notable dividend for the Greek market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of BIOKA's dividend in 3 years as they are not forecast to pay a notable one for the Greek market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

10.7yrs

Average board tenure


CEO

Ioannis Kantonias

no data

Tenure

Mr. Ioannis Asteriou Kantonias has been President of the Board at Biokarpet S.A. since 1981 and serves as its Chief Executive Officer. Mr. Kantonias has experience in the carpet industry. He served as Dome...


Board Members

Experienced Board: BIOKA's board of directors are seasoned and experienced ( 10.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Biokarpet S.A.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Biokarpet S.A.
  • Ticker: BIOKA
  • Exchange: ATSE
  • Founded: 1950
  • Industry: Aluminum
  • Sector: Materials
  • Market Cap: €28.544m
  • Shares outstanding: 23.99m
  • Website: https://www.biokarpet.gr

Number of Employees


Location

  • Biokarpet S.A.
  • 5th klm. Old National Road Larissa
  • PO BOX 1129
  • Athens
  • 41110
  • Greece

Listings


Biography

Biokarpet S.A. engages in the metallurgy, textile, and information technology sectors in Greece, rest of European union, and internationally. The company produces and trades in handmade and machine-made ca...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/10 16:23
End of Day Share Price2021/05/10 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.